A comprehensive study of 226 patients from Australia suggests a strong association between HPV positivity and downregulation or absent expression of Cyclin D1.In an HPV-positive tumour group, Cyclin D1-positive cancers had 8 fold-increased risk of poor prognosis compared to Cyclin D1-negative cancers with 3.3 years overall survival. Here, CCND1 is linked to neoplasm.